No products in the cart.
Rybelsus® (semaglutide) will be the first ORAL GLP-1 agonist for type 2 diabetes…it’s a tablet version [...]
Mayzent® (siponimod) will be a new oral treatment for secondary progressive multiple sclerosis (MS) in adults. [...]
SGLT2 inhibitor (Jardiance®, Invokana®, Forxiga®, etc) risks are in the spotlight again. SGLT2 stands for [...]
The information contained in this evidence table is emerging and rapidly evolving because of ongoing [...]
Current treatment evidence of hydroxychloroquine in COVID-19
(April 14 2020) [...]
Constipation requires a tailored approach as every person and episode is different [...]
DRUG INTERACTIONS In vivo drug interactions studies have shown that ketoconazole strongly inhibits the CYP3A4-dependent [...]
ADVERSE REACTIONS Domperidone (aka Motilium®) is a very well tolerated drug and has been on [...]
Domperidone is a what we call a “Gastrointestinal Motility Modifier”. Indications- What is domperidone used [...]
You’ll see a shift in meds to treat Clostridium difficile in adults…due to new guidelines from the Infect [...]
Username or email address *
Log in Remember me
Lost your password?
Email address *